BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37908671)

  • 21. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer.
    Wang Y; Lan M; Shen D; Fang K; Zhu L; Liu Y; Hao L; Li P
    Int J Nanomedicine; 2020; 15():4289-4309. PubMed ID: 32606678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indocyanine Green-Loaded Nanobubbles Targeting Carbonic Anhydrase IX for Multimodal Imaging of Renal Cell Carcinoma.
    Zhong C; Chen J; Ling Y; Liu D; Xu J; Wang L; Ge C; Jiang Q
    Int J Nanomedicine; 2023; 18():2757-2776. PubMed ID: 37250472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
    Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
    Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gold Nanorods and Polymer Micelles Mediated Dual TLR Stimulators Delivery System CPG@Au NRs/M-R848 Regulate Macrophages Reprogramming and DC Maturation for Enhanced Photothermal Immunotherapy of Melanoma.
    Jia Y; Shi K; Dai L; He X; Deng H; Han R; Yang F; Chu B; Liao J; Wei X; Qian Z
    Small Methods; 2023 May; 7(5):e2201087. PubMed ID: 36572641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxygen-sufficient lipid nanobubbles combined with UTMD for enhanced sonodynamic therapy of Hep-G2 cells.
    Tan H; Tian Y; Yang H; Liu Z; Liang X; Li B; Cheng W
    J Biomed Mater Res B Appl Biomater; 2021 Nov; 109(11):1796-1806. PubMed ID: 33838006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
    Anfray C; Mainini F; Digifico E; Maeda A; Sironi M; Erreni M; Anselmo A; Ummarino A; Gandoy S; Expósito F; Redrado M; Serrano D; Calvo A; Martens M; Bravo S; Mantovani A; Allavena P; Andón FT
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity.
    Li Y; Chen W; Kang Y; Zhen X; Zhou Z; Liu C; Chen S; Huang X; Liu HJ; Koo S; Kong N; Ji X; Xie T; Tao W
    Nat Commun; 2023 Nov; 14(1):6973. PubMed ID: 37914681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single Atom Catalysts Remodel Tumor Microenvironment for Augmented Sonodynamic Immunotherapy.
    Geng B; Hu J; He X; Zhang Z; Cai J; Pan D; Shen L
    Adv Mater; 2024 Jun; 36(25):e2313670. PubMed ID: 38490191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma.
    Tsuda T; Kaibori M; Hishikawa H; Nakatake R; Okumura T; Ozeki E; Hara I; Morimoto Y; Yoshii K; Kon M
    PLoS One; 2017; 12(8):e0183527. PubMed ID: 28859104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages.
    Zhou J; Wang W; Li Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):73. PubMed ID: 33596985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study.
    Thauvin C; Widmer J; Mottas I; Hocevar S; Allémann E; Bourquin C; Delie F
    Eur J Pharm Biopharm; 2019 Jun; 139():253-261. PubMed ID: 30981947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice.
    Liu Y; Xie Q; Ma Y; Lin C; Li J; Hu B; Liu C; Zhao Y
    Int J Pharm; 2022 Dec; 629():122352. PubMed ID: 36374798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.
    Luo J; Wang X; Shi Z; Zeng Y; He L; Cao J; Sun Y; Zhang T; Huang P
    J Nanobiotechnology; 2022 May; 20(1):228. PubMed ID: 35568916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.
    Li L; Zou Y; Wang L; Yang L; Li Y; Liao A; Chen Z; Yu Z; Guo J; Han S
    Int J Pharm; 2023 Jul; 642():123114. PubMed ID: 37301243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSH/pH dual response drug delivery system for photothermal enhanced gene-immunotherapy.
    Ma T; Li W; Ye J; Huang C; Li Y; Qiu H; Yin S
    Nanoscale; 2023 Nov; 15(42):16947-16958. PubMed ID: 37779508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric STING Pro-agonists for Tumor-Specific Sonodynamic Immunotherapy.
    Yu J; He S; Zhang C; Xu C; Huang J; Xu M; Pu K
    Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202307272. PubMed ID: 37312610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
    Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
    Front Immunol; 2020; 11():1037. PubMed ID: 32547550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.